Market Overview

The global glyphosate market is projected to reach USD 12.54 billion by 2024, with a CAGR of 6.8% over the forecast period, 2019-2024. With the area under herbicide-tolerant crops increasing and with more and more countries approving herbicide-tolerance technology for crops, the market is expected to grow inorganically with rapid farmer adoption. Concerns with respect to the environmental hazards remain in developed markets, but the market is not expected to slow down, on account of the lack of availability of efficient alternatives to glyphosate.

Scope of the Report


Glyphosate is one of the most commonly used herbicides. It is classified as a post-emergent, non-selective, systemic herbicide, capable of killing weeds which have green foliage. Usage on herbicide-tolerant crops, in zero tillage applications, usage on perennial crops constitute the major agricultural applications of the herbicide while it is also used in non-agricultural operations such as home-based weed control, industrial weed control, municipal weed control, etc. The market is also segmented by different crop types as well as by geography.

Key Market Trends


Approvals for Herbicide-Tolerant Crop Hybrids Essential to Drive Inorganic Growth

Herbicide-Tolerant crop hybrids are genetically engineered hybrids where the crops are tolerant to non-selective herbicides such as glyphosate. Since glyphosate is the most efficient herbicide which helps in complete control of weeds, irrespective of species and physiology, most of the research and development activities are targeted at glyphosate tolerance. Bayer Cropscience, which completed the acquisition of Monsanto Company in 2018 holds the patent for RoundUp-Ready hybrids in crops such as soybean, corn, and cotton, with Roundup-Ready Soybeans holding a large share of the acreage in the United States, Brazil, and Argentina. The adoption of herbicide-tolerance technology at the farmer-level is expected to be rapid, but the long-pending approval backlog with the government agencies in India and countries of the European Union are stalling the growth spurt that could aid the inorganic growth in the global glyphosate market.

Asia-Pacific and North America Equally Attractive Regional Markets

The Asia-Pacific region and the North American Region present equally attractive opportunities for companies operating in the glyphosate herbicide market. On account of the increasing levels of penetration of herbicide-tolerant hybrids, the North American region is expected to remain as one of the fastest-growing regions. It is estimated that almost 56% of the glyphosate usage in the United States is for herbicide-tolerant crops.

In the Asia-Pacific region, the growth in the market is expected to be more organic in nature. The region has the highest arable land in the world with the highest crop diversity. Increased adoption of advanced agricultural practices such as zero-tillage is expected to deliver growth to the glyphosate herbicide market in the region. Although China has provided approval to grow herbicide-tolerant hybrids, the constraint remains with respect to India, which is yet to provide approvals for any genetically modified hybrid in food crops.

Competitive Landscape


In the global glyphosate market, companies are not only competing in terms of product quality and product promotion, but are also focusing on strategic moves to acquire greater market shares. New product launches, expansions, innovations, and partnerships are the major strategies adopted by the leading companies in the glyphosate herbicide market. Bayer CropScience AG, with its acquisition of Monsanto Company, holds the pole position in the market, while the off-patent nature of glyphosate means that there are a host of generic crop protection chemical manufacturers that vie for a share in this highly competitive market. At a global level, the market is fairly fragmented due to this effect.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client’s requirements
  • 3 months of analyst support